Dowling & Yahnke LLC Bristol Myers Squibb CO Transaction History

Dowling & Yahnke LLC

  • $215 Million
  • Q3 2022

A detailed history of Dowling & Yahnke LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Dowling & Yahnke LLC holds 112,413 shares of BMY stock, worth $6.49 Million. This represents 3.72% of its overall portfolio holdings.

Number of Shares
112,413
Previous 114,436 1.77%
Holding current value
$6.49 Million
Previous $8.81 Million 9.32%
% of portfolio
3.72%
Previous 0.41%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 02, 2022
SELL
$0.13 - $76.84 $262 - $155,447
-2,023 Reduced 1.77%
112,413 $7.99 Million
Q2 2022

Aug 10, 2022
BUY
$72.62 - $79.98 $341,386 - $375,985
4,701 Added 4.28%
114,436 $8.81 Million
Q1 2022

May 04, 2022
BUY
$61.48 - $73.72 $149,519 - $179,287
2,432 Added 2.27%
109,735 $8.01 Million
Q4 2021

Feb 10, 2022
SELL
$53.63 - $62.52 $253,026 - $294,969
-4,718 Reduced 4.21%
107,303 $6.69 Million
Q3 2021

Nov 12, 2021
SELL
$59.17 - $69.31 $70,944 - $83,102
-1,199 Reduced 1.06%
112,021 $6.63 Million
Q2 2021

Jul 21, 2021
BUY
$61.91 - $67.42 $43,460 - $47,328
702 Added 0.62%
113,220 $7.57 Million
Q1 2021

Apr 29, 2021
BUY
$59.34 - $66.74 $42,368 - $47,652
714 Added 0.64%
112,518 $7.1 Million
Q4 2020

Jan 28, 2021
BUY
$57.74 - $65.43 $101,045 - $114,502
1,750 Added 1.59%
111,804 $6.94 Million
Q3 2020

Oct 19, 2020
SELL
$57.43 - $63.64 $133,467 - $147,899
-2,324 Reduced 2.07%
110,054 $6.64 Million
Q2 2020

Jul 31, 2020
BUY
$54.82 - $64.09 $183,537 - $214,573
3,348 Added 3.07%
112,378 $6.61 Million
Q1 2020

May 15, 2020
SELL
$46.4 - $67.43 $257,984 - $374,910
-5,560 Reduced 4.85%
109,030 $6.08 Million
Q4 2019

Jan 27, 2020
BUY
$49.21 - $64.19 $1.37 Million - $1.79 Million
27,920 Added 32.21%
114,590 $7.36 Million
Q3 2019

Oct 29, 2019
SELL
$42.77 - $50.71 $56,114 - $66,531
-1,312 Reduced 1.49%
86,670 $4.4 Million
Q2 2019

Jul 22, 2019
SELL
$44.62 - $49.34 $251,835 - $278,474
-5,644 Reduced 6.03%
87,982 $3.99 Million
Q1 2019

Apr 30, 2019
BUY
$45.12 - $53.8 $166,267 - $198,253
3,685 Added 4.1%
93,626 $4.47 Million
Q4 2018

Jan 24, 2019
SELL
$48.76 - $63.23 $101,859 - $132,087
-2,089 Reduced 2.27%
89,941 $4.81 Million
Q3 2018

Oct 30, 2018
SELL
$55.19 - $62.25 $41,723 - $47,061
-756 Reduced 0.81%
92,030 $5.71 Million
Q2 2018

Jul 30, 2018
SELL
$50.53 - $62.98 $248,405 - $309,609
-4,916 Reduced 5.03%
92,786 $5.14 Million
Q1 2018

May 01, 2018
SELL
$59.92 - $68.98 $94,733 - $109,057
-1,581 Reduced 1.59%
97,702 $6.18 Million
Q4 2017

Feb 02, 2018
SELL
$59.94 - $65.35 $182,697 - $199,186
-3,048 Reduced 2.98%
99,283 $6.08 Million
Q3 2017

Nov 08, 2017
BUY
$55.23 - $63.74 $5.65 Million - $6.52 Million
102,331
102,331 $6.52 Million

Others Institutions Holding BMY

# of Institutions
2,536
Shares Held
1.47B
Call Options Held
31.6M
Put Options Held
35M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Dowling & Yahnke LLC Portfolio

Follow Dowling & Yahnke LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dowling & Yahnke LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dowling & Yahnke LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email